These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11966438)

  • 1. Modulation of cytotoxicity of benzamide riboside by expression of NMN adenylyltransferase.
    Yalowitz JA; Jayaram HN
    Curr Med Chem; 2002 Apr; 9(7):749-58. PubMed ID: 11966438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
    Jayaram HN; Cooney DA; Grusch M; Krupitza G
    Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of action of benzamide riboside: a novel inhibitor of IMP dehydrogenase.
    Gharehbaghi K; Grünberger W; Jayaram HN
    Curr Med Chem; 2002 Apr; 9(7):743-8. PubMed ID: 11966437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.
    Gharehbaghi K; Sreenath A; Hao Z; Paull KD; Szekeres T; Cooney DA; Krohn K; Jayaram HN
    Biochem Pharmacol; 1994 Oct; 48(7):1413-9. PubMed ID: 7945441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of the novel IMP dehydrogenase inhibitor benzamide riboside.
    Jäger W; Salamon A; Szekeres T
    Curr Med Chem; 2002 Apr; 9(7):781-6. PubMed ID: 11966442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targets of guanine nucleotides in differentiation, proliferation and apoptosis.
    Yalowitz JA; Jayaram HN
    Anticancer Res; 2000; 20(4):2329-38. PubMed ID: 10953293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity and characterization of an active metabolite of benzamide riboside, a novel inhibitor of IMP dehydrogenase.
    Gharehbaghi K; Paull KD; Kelley JA; Barchi JJ; Marquez VE; Cooney DA; Monks A; Scudiero D; Krohn K; Jayaram HN
    Int J Cancer; 1994 Mar; 56(6):892-9. PubMed ID: 7907081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside.
    Pankiewicz KW; Watanabe KA; Lesiak-Watanabe K; Goldstein BM; Jayaram HN
    Curr Med Chem; 2002 Apr; 9(7):733-41. PubMed ID: 11966436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical consequences of resistance to a recently discovered IMP dehydrogenase inhibitor, benzamide riboside, in human myelogenous leukemia K562 cells.
    Jayaram HN; O'Connor A; Grant MR; Yang H; Grieco PA; Cooney DA
    J Exp Ther Oncol; 1996 Sep; 1(5):278-85. PubMed ID: 9414415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P; Grifantini M
    Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside.
    Damaraju VL; Visser F; Zhang J; Mowles D; Ng AM; Young JD; Jayaram HN; Cass CE
    Mol Pharmacol; 2005 Jan; 67(1):273-9. PubMed ID: 15486050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity and efficacy of benzamide riboside in cancer chemotherapy models.
    Jayaram HN; Yalowitz JA; Arguello F; Greene JF
    Curr Med Chem; 2002 Apr; 9(7):787-92. PubMed ID: 11966443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential mechanisms of benzamide riboside mediated cell death.
    Polgar D; Gfatter S; Uhl M; Kassie F; Leisser C; Krupitza G; Grusch M
    Curr Med Chem; 2002 Apr; 9(7):765-71. PubMed ID: 11966440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells.
    Khanna N; Jayaram HN; Singh N
    Life Sci; 2004 May; 75(2):179-90. PubMed ID: 15120570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells.
    Jayaram HN; Gharehbaghi K; Jayaram NH; Rieser J; Krohn K; Paull KD
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1600-6. PubMed ID: 1354960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMNAT expression and its relation to NAD metabolism.
    Jayaram HN; Kusumanchi P; Yalowitz JA
    Curr Med Chem; 2011; 18(13):1962-72. PubMed ID: 21517776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sensitivity of ovarian carcinoma cell lines to apoptosis induced by the IMPDH inhibitor benzamide riboside.
    Hunáková L; Bies J; Sedlák J; Duraj J; Jakubíková J; Takácsová X; Novotný L; Chorváth B
    Neoplasma; 2000; 47(5):274-9. PubMed ID: 11130242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzamide riboside, a recent inhibitor of inosine 5'-monophosphate dehydrogenase induces transferrin receptors in cancer cells.
    Szekeres T; Sedlak J; Novotny L
    Curr Med Chem; 2002 Apr; 9(7):759-64. PubMed ID: 11966439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity.
    Cooney DA; Jayaram HN; Glazer RI; Kelley JA; Marquez VE; Gebeyehu G; Van Cott AC; Zwelling LA; Johns DG
    Adv Enzyme Regul; 1983; 21():271-303. PubMed ID: 6152729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and action of benzamide riboside in Chinese hamster ovary cells.
    Saunders PP; Arimilli S; Krohn K; Muhs MA; Alvarez E; Surve-lyer R
    Anticancer Drugs; 1996 Jan; 7(1):93-9. PubMed ID: 8742104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.